Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |